Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Iterum Therapeutics plc
| Metric | Iterum Therapeutics plc ITRMFHealthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | — |
| Net income (latest) | −$25M |
| Operating margin | — |
| Net margin | — |
| Return on equity | 607.1% |
| Return on assets | −55.6% |
| Return on capital (ROCE) | −69.3% |
| Debt / equity | — |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -37.38 |
| Accruals / assets | 4.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.